Quest said Solstas is based in Greensboro, N.C., and it runs commercial labs in nine states across the southeastern U.S. Quest said the deal should increase its annual revenue by about 5 percent, and it will make a small addition to adjusted net income in 2014. It said the purchase should close during the first half of the year.